By expenditures
| Name | Title | Type |
|---|---|---|
| Carrie Anthony | CFO | Auditee |
| Christopher Walton | Principal | Auditee |
| David McClay | CEO | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 324580 | 2023 | 2024-10-12 | Cliftonlarsonallen LLP | $2.25M |
| 27021 | 2022 | 2022-12-15 | Cliftonlarsonallen LLP | $1.30M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 324580 | 2023 | 2024-10-12 | 1079028 | 2023-008 | Material Weakness | - | AB |
| 324580 | 2023 | 2024-10-12 | 1079027 | 2023-007 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 1079026 | 2023-002 | Significant Deficiency | - | ABC |
| 324580 | 2023 | 2024-10-12 | 1079025 | 2023-006 | Material Weakness | - | AB |
| 324580 | 2023 | 2024-10-12 | 1079024 | 2023-002 | Significant Deficiency | - | ABC |
| 324580 | 2023 | 2024-10-12 | 1079023 | 2023-007 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 1079022 | 2023-005 | Significant Deficiency | - | ABCH |
| 324580 | 2023 | 2024-10-12 | 1079021 | 2023-002 | Significant Deficiency | - | ABC |
| 324580 | 2023 | 2024-10-12 | 1079020 | 2023-008 | Material Weakness | - | AB |
| 324580 | 2023 | 2024-10-12 | 1079019 | 2023-007 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 1079018 | 2023-006 | Material Weakness | - | AB |
| 324580 | 2023 | 2024-10-12 | 1079017 | 2023-005 | Significant Deficiency | - | ABCH |
| 324580 | 2023 | 2024-10-12 | 1079016 | 2023-004 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 1079015 | 2023-003 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 1079014 | 2023-002 | Significant Deficiency | - | ABC |
| 324580 | 2023 | 2024-10-12 | 1079013 | 2023-001 | Significant Deficiency | Yes | H |
| 324580 | 2023 | 2024-10-12 | 502586 | 2023-008 | Material Weakness | - | AB |
| 324580 | 2023 | 2024-10-12 | 502585 | 2023-007 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 502584 | 2023-002 | Significant Deficiency | - | ABC |
| 324580 | 2023 | 2024-10-12 | 502583 | 2023-006 | Material Weakness | - | AB |
| 324580 | 2023 | 2024-10-12 | 502582 | 2023-002 | Significant Deficiency | - | ABC |
| 324580 | 2023 | 2024-10-12 | 502581 | 2023-007 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 502580 | 2023-005 | Significant Deficiency | - | ABCH |
| 324580 | 2023 | 2024-10-12 | 502579 | 2023-002 | Significant Deficiency | - | ABC |
| 324580 | 2023 | 2024-10-12 | 502578 | 2023-008 | Material Weakness | - | AB |
| 324580 | 2023 | 2024-10-12 | 502577 | 2023-007 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 502576 | 2023-006 | Material Weakness | - | AB |
| 324580 | 2023 | 2024-10-12 | 502575 | 2023-005 | Significant Deficiency | - | ABCH |
| 324580 | 2023 | 2024-10-12 | 502574 | 2023-004 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 502573 | 2023-003 | Significant Deficiency | - | AB |
| 324580 | 2023 | 2024-10-12 | 502572 | 2023-002 | Significant Deficiency | - | ABC |
| 324580 | 2023 | 2024-10-12 | 502571 | 2023-001 | Significant Deficiency | Yes | H |
| 27021 | 2022 | 2022-12-15 | 607492 | 2022-002 | Significant Deficiency | - | H |
| 27021 | 2022 | 2022-12-15 | 607491 | 2022-002 | Significant Deficiency | - | H |
| 27021 | 2022 | 2022-12-15 | 607490 | 2022-002 | Significant Deficiency | - | H |
| 27021 | 2022 | 2022-12-15 | 31050 | 2022-002 | Significant Deficiency | - | H |
| 27021 | 2022 | 2022-12-15 | 31049 | 2022-002 | Significant Deficiency | - | H |
| 27021 | 2022 | 2022-12-15 | 31048 | 2022-002 | Significant Deficiency | - | H |